Global PARP Poly ADP Ribose Polymerase Inhibitor Market Research Report 2023(Status and Outlook)

Global PARP Poly ADP Ribose Polymerase Inhibitor Market Research Report 2023(Status and Outlook)



Report Overview

PARP inhibitors are a group of pharmacological inhibitors of the enzyme poly ADP ribose polymerase (PARP).

They are developed for multiple indications; the most important is the treatment of cancer. Several forms of cancer are more dependent on PARP than regular cells, making PARP an attractive target for cancer therapy. PARP inhibitors appear to improve progression-free survival in women with recurrent platinum-sensitive ovarian cancer, as evidenced mainly by olaparib added to conventional treatment.

In our report, we only study four approved PARPi (Lynparza, Zejula, Rubraca and Talzenna). One unit is one tablet or one capsule.

Global PARP (Poly ADP-Ribose Polymerase) Inhibitor key players include AstraZeneca, Tesaro, Merck & Co, etc. Global top three manufacturers hold a share about 90%.

North America is the largest market, with a share about 70%, followed by Europe and Emerging Country, both have a share about 25 percent.

In terms of product, Lynparza is the largest segment, with a share over 65%. And in terms of application, the largest application is Ovarian Cancer, followed by Breast Cancer.

The Global PARP Poly ADP Ribose Polymerase Inhibitor Market Size was estimated at USD 3304.50 million in 2022 and is projected to reach USD 6002.07 million by 2029, exhibiting a CAGR of 8.90% during the forecast period.

Bosson Research’s latest report provides a deep insight into the global PARP Poly ADP Ribose Polymerase Inhibitor market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global PARP Poly ADP Ribose Polymerase Inhibitor Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the PARP Poly ADP Ribose Polymerase Inhibitor market in any manner.

Global PARP Poly ADP Ribose Polymerase Inhibitor Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

AstraZeneca

Tesaro

Merck & Co

Clovis Oncology

Pfizer

GSK

Zai Lab

Market Segmentation (by Type)

Lynparza

Zejula

Rubraca

Talzenna

Other

Market Segmentation (by Application)

Commercial

Individual Consumption

Others

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the PARP Poly ADP Ribose Polymerase Inhibitor Market

Overview of the regional outlook of the PARP Poly ADP Ribose Polymerase Inhibitor Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of PARP Poly ADP Ribose Polymerase Inhibitor
1.2 Key Market Segments
1.2.1 PARP Poly ADP Ribose Polymerase Inhibitor Segment by Type
1.2.2 PARP Poly ADP Ribose Polymerase Inhibitor Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PARP Poly ADP Ribose Polymerase Inhibitor Market Overview
2.1 Global Market Overview
2.1.1 Global PARP Poly ADP Ribose Polymerase Inhibitor Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global PARP Poly ADP Ribose Polymerase Inhibitor Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PARP Poly ADP Ribose Polymerase Inhibitor Market Competitive Landscape
3.1 Global PARP Poly ADP Ribose Polymerase Inhibitor Sales by Manufacturers (2018-2023)
3.2 Global PARP Poly ADP Ribose Polymerase Inhibitor Revenue Market Share by Manufacturers (2018-2023)
3.3 PARP Poly ADP Ribose Polymerase Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global PARP Poly ADP Ribose Polymerase Inhibitor Average Price by Manufacturers (2018-2023)
3.5 Manufacturers PARP Poly ADP Ribose Polymerase Inhibitor Sales Sites, Area Served, Product Type
3.6 PARP Poly ADP Ribose Polymerase Inhibitor Market Competitive Situation and Trends
3.6.1 PARP Poly ADP Ribose Polymerase Inhibitor Market Concentration Rate
3.6.2 Global 5 and 10 Largest PARP Poly ADP Ribose Polymerase Inhibitor Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PARP Poly ADP Ribose Polymerase Inhibitor Industry Chain Analysis
4.1 PARP Poly ADP Ribose Polymerase Inhibitor Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of PARP Poly ADP Ribose Polymerase Inhibitor Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PARP Poly ADP Ribose Polymerase Inhibitor Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global PARP Poly ADP Ribose Polymerase Inhibitor Sales Market Share by Type (2018-2023)
6.3 Global PARP Poly ADP Ribose Polymerase Inhibitor Market Size Market Share by Type (2018-2023)
6.4 Global PARP Poly ADP Ribose Polymerase Inhibitor Price by Type (2018-2023)
7 PARP Poly ADP Ribose Polymerase Inhibitor Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global PARP Poly ADP Ribose Polymerase Inhibitor Market Sales by Application (2018-2023)
7.3 Global PARP Poly ADP Ribose Polymerase Inhibitor Market Size (M USD) by Application (2018-2023)
7.4 Global PARP Poly ADP Ribose Polymerase Inhibitor Sales Growth Rate by Application (2018-2023)
8 PARP Poly ADP Ribose Polymerase Inhibitor Market Segmentation by Region
8.1 Global PARP Poly ADP Ribose Polymerase Inhibitor Sales by Region
8.1.1 Global PARP Poly ADP Ribose Polymerase Inhibitor Sales by Region
8.1.2 Global PARP Poly ADP Ribose Polymerase Inhibitor Sales Market Share by Region
8.2 North America
8.2.1 North America PARP Poly ADP Ribose Polymerase Inhibitor Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe PARP Poly ADP Ribose Polymerase Inhibitor Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific PARP Poly ADP Ribose Polymerase Inhibitor Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America PARP Poly ADP Ribose Polymerase Inhibitor Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa PARP Poly ADP Ribose Polymerase Inhibitor Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 AstraZeneca
9.1.1 AstraZeneca PARP Poly ADP Ribose Polymerase Inhibitor Basic Information
9.1.2 AstraZeneca PARP Poly ADP Ribose Polymerase Inhibitor Product Overview
9.1.3 AstraZeneca PARP Poly ADP Ribose Polymerase Inhibitor Product Market Performance
9.1.4 AstraZeneca Business Overview
9.1.5 AstraZeneca PARP Poly ADP Ribose Polymerase Inhibitor SWOT Analysis
9.1.6 AstraZeneca Recent Developments
9.2 Tesaro
9.2.1 Tesaro PARP Poly ADP Ribose Polymerase Inhibitor Basic Information
9.2.2 Tesaro PARP Poly ADP Ribose Polymerase Inhibitor Product Overview
9.2.3 Tesaro PARP Poly ADP Ribose Polymerase Inhibitor Product Market Performance
9.2.4 Tesaro Business Overview
9.2.5 Tesaro PARP Poly ADP Ribose Polymerase Inhibitor SWOT Analysis
9.2.6 Tesaro Recent Developments
9.3 Merck andamp; Co
9.3.1 Merck andamp; Co PARP Poly ADP Ribose Polymerase Inhibitor Basic Information
9.3.2 Merck andamp; Co PARP Poly ADP Ribose Polymerase Inhibitor Product Overview
9.3.3 Merck andamp; Co PARP Poly ADP Ribose Polymerase Inhibitor Product Market Performance
9.3.4 Merck andamp; Co Business Overview
9.3.5 Merck andamp; Co PARP Poly ADP Ribose Polymerase Inhibitor SWOT Analysis
9.3.6 Merck andamp; Co Recent Developments
9.4 Clovis Oncology
9.4.1 Clovis Oncology PARP Poly ADP Ribose Polymerase Inhibitor Basic Information
9.4.2 Clovis Oncology PARP Poly ADP Ribose Polymerase Inhibitor Product Overview
9.4.3 Clovis Oncology PARP Poly ADP Ribose Polymerase Inhibitor Product Market Performance
9.4.4 Clovis Oncology Business Overview
9.4.5 Clovis Oncology PARP Poly ADP Ribose Polymerase Inhibitor SWOT Analysis
9.4.6 Clovis Oncology Recent Developments
9.5 Pfizer
9.5.1 Pfizer PARP Poly ADP Ribose Polymerase Inhibitor Basic Information
9.5.2 Pfizer PARP Poly ADP Ribose Polymerase Inhibitor Product Overview
9.5.3 Pfizer PARP Poly ADP Ribose Polymerase Inhibitor Product Market Performance
9.5.4 Pfizer Business Overview
9.5.5 Pfizer PARP Poly ADP Ribose Polymerase Inhibitor SWOT Analysis
9.5.6 Pfizer Recent Developments
9.6 GSK
9.6.1 GSK PARP Poly ADP Ribose Polymerase Inhibitor Basic Information
9.6.2 GSK PARP Poly ADP Ribose Polymerase Inhibitor Product Overview
9.6.3 GSK PARP Poly ADP Ribose Polymerase Inhibitor Product Market Performance
9.6.4 GSK Business Overview
9.6.5 GSK Recent Developments
9.7 Zai Lab
9.7.1 Zai Lab PARP Poly ADP Ribose Polymerase Inhibitor Basic Information
9.7.2 Zai Lab PARP Poly ADP Ribose Polymerase Inhibitor Product Overview
9.7.3 Zai Lab PARP Poly ADP Ribose Polymerase Inhibitor Product Market Performance
9.7.4 Zai Lab Business Overview
9.7.5 Zai Lab Recent Developments
10 PARP Poly ADP Ribose Polymerase Inhibitor Market Forecast by Region
10.1 Global PARP Poly ADP Ribose Polymerase Inhibitor Market Size Forecast
10.2 Global PARP Poly ADP Ribose Polymerase Inhibitor Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe PARP Poly ADP Ribose Polymerase Inhibitor Market Size Forecast by Country
10.2.3 Asia Pacific PARP Poly ADP Ribose Polymerase Inhibitor Market Size Forecast by Region
10.2.4 South America PARP Poly ADP Ribose Polymerase Inhibitor Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of PARP Poly ADP Ribose Polymerase Inhibitor by Country
11 Forecast Market by Type and by Application (2024-2029)
11.1 Global PARP Poly ADP Ribose Polymerase Inhibitor Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of PARP Poly ADP Ribose Polymerase Inhibitor by Type (2024-2029)
11.1.2 Global PARP Poly ADP Ribose Polymerase Inhibitor Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of PARP Poly ADP Ribose Polymerase Inhibitor by Type (2024-2029)
11.2 Global PARP Poly ADP Ribose Polymerase Inhibitor Market Forecast by Application (2024-2029)
11.2.1 Global PARP Poly ADP Ribose Polymerase Inhibitor Sales (K MT) Forecast by Application
11.2.2 Global PARP Poly ADP Ribose Polymerase Inhibitor Market Size (M USD) Forecast by Application (2024-2029)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings